462 related articles for article (PubMed ID: 28689433)
1. Experimental and early investigational drugs for androgenetic alopecia.
Guo H; Gao WV; Endo H; McElwee KJ
Expert Opin Investig Drugs; 2017 Aug; 26(8):917-932. PubMed ID: 28689433
[TBL] [Abstract][Full Text] [Related]
2. New investigational drugs for androgenetic alopecia.
Valente Duarte de Sousa IC; Tosti A
Expert Opin Investig Drugs; 2013 May; 22(5):573-89. PubMed ID: 23550739
[TBL] [Abstract][Full Text] [Related]
3. New drugs under investigation for the treatment of alopecias.
Ocampo-Garza J; Griggs J; Tosti A
Expert Opin Investig Drugs; 2019 Mar; 28(3):275-284. PubMed ID: 30642204
[TBL] [Abstract][Full Text] [Related]
4. Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options.
Vasserot AP; Geyfman M; Poloso NJ
Expert Opin Ther Targets; 2019 Sep; 23(9):755-771. PubMed ID: 31456448
[No Abstract] [Full Text] [Related]
5. Androgen metabolism as it affects hair growth in androgenetic alopecia.
Kaufman KD
Dermatol Clin; 1996 Oct; 14(4):697-711. PubMed ID: 9238328
[TBL] [Abstract][Full Text] [Related]
6. A bald statement - Current approaches to manipulate miniaturisation focus only on promoting hair growth.
Pantelireis N; Higgins CA
Exp Dermatol; 2018 Sep; 27(9):959-965. PubMed ID: 29787625
[TBL] [Abstract][Full Text] [Related]
7. Investigational medications in the treatment of alopecia.
Poulos GA; Mirmirani P
Expert Opin Investig Drugs; 2005 Feb; 14(2):177-84. PubMed ID: 15757393
[TBL] [Abstract][Full Text] [Related]
8. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
9. Emerging treatments in alopecia.
Falto-Aizpurua L; Choudhary S; Tosti A
Expert Opin Emerg Drugs; 2014 Dec; 19(4):545-56. PubMed ID: 25330928
[TBL] [Abstract][Full Text] [Related]
10. Safety concerns when using novel medications to treat alopecia.
Almohanna HM; Perper M; Tosti A
Expert Opin Drug Saf; 2018 Nov; 17(11):1115-1128. PubMed ID: 30318935
[TBL] [Abstract][Full Text] [Related]
11. New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach.
Sadick NS; Callender VD; Kircik LH; Kogan S
J Drugs Dermatol; 2017 Nov; 16(11):s135-s140. PubMed ID: 29141068
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles.
Randall VA; Jenner TJ; Hibberts NA; De Oliveira IO; Vafaee T
J Endocrinol; 2008 Apr; 197(1):11-23. PubMed ID: 18372228
[TBL] [Abstract][Full Text] [Related]
13. A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia.
Gupta AK; Carviel J
Dermatol Surg; 2016 Dec; 42(12):1335-1339. PubMed ID: 27631460
[TBL] [Abstract][Full Text] [Related]
14. The topical penta-peptide Gly-Pro-Ile-Gly-Ser increases the proportion of thick hair in Japanese men with androgenetic alopecia.
Iwabuchi T; Takeda S; Yamanishi H; Ideta R; Ehama R; Tsuruda A; Shibata H; Ito T; Komatsu N; Terai K; Oka S
J Cosmet Dermatol; 2016 Jun; 15(2):176-84. PubMed ID: 27030543
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
16. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
Hamada K; Randall VA
Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
[TBL] [Abstract][Full Text] [Related]
18. Partial reversal of androgenetic alopecia with methotrexate therapy for psoriasis.
Famenini S; Wu JJ
Cutis; 2013 Sep; 92(3):127-8. PubMed ID: 24153140
[TBL] [Abstract][Full Text] [Related]
19. Evaluating hair growth promoting effects of candidate substance: A review of research methods.
Ohn J; Kim KH; Kwon O
J Dermatol Sci; 2019 Mar; 93(3):144-149. PubMed ID: 30904351
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
